| Symbol | Company | Owner | Relationship | Date | Transaction | Cost | # Shares | Value ($) | Total Shares | Filing | |
|---|---|---|---|---|---|---|---|---|---|---|---|
| ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | Chief Executive Officer | Sep 22, 2022 | Buy | $2.10 | 10,000 | 21,042 | 1,040,000 | Sep 23, 2022, 10:58 AM | |
| ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO | Aug 20, 2021 | Buy | $4.32 | 10,000 | 43,200 | 1,030,000 | Aug 20, 2021, 04:06 PM | |
| ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO | Aug 13, 2019 | Buy | $6.15 | 5,000 | 30,750 | 1,025,000 | Aug 13, 2019, 04:04 PM | |
| ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO | May 20, 2019 | Buy | $7.78 | 1,400 | 10,895 | 1,011,400 | May 22, 2019, 04:25 PM | |
| ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO | May 21, 2019 | Buy | $7.96 | 8,600 | 68,431 | 1,020,000 | May 22, 2019, 04:25 PM | |
| ETON | Eton Pharmaceuticals, Inc. | BRYNJELSEN SEAN | President & CEO | Nov 15, 2018 | Buy | $6.00 | 10,000 | 60,000 | 1,010,000 | Nov 15, 2018, 07:23 PM | |
| SGNT | Sagent Pharmaceuticals, Inc. | BRYNJELSEN SEAN | EVP, Business Development | Aug 29, 2016 | Option Exercise | $21.75 | 9,844 | 214,107 | 0 | Aug 31, 2016, 06:21 PM |
Menu